-
New vaccine for prevention of Ebola virus disease recommended for approval in the EU
expresspharma
June 01, 2020
The new Ebola vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.
-
Operation Warp Speed: developing, manufacturing and distributing COVID-19 medical countermeasures
europeanpharmaceuticalreview
May 26, 2020
Exploring Operation Warp Speed, the Trump Administration’s program to expedite R&D, manufacturing and distribution of medical countermeasures for COVID-19.
-
Two malaria vaccine candidates show signs of efficacy
europeanpharmaceuticalreview
May 26, 2020
Clinical trials testing potential malaria vaccines report the vaccines were well tolerated and demonstrated some efficacy, delaying Plasmodium falciparum infection.
-
Akers, Premas Biotech Announce Successful Completion of Vaccine Prototype
americanpharmaceuticalreview
May 20, 2020
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
-
Premas Biotech announces completion of vaccine prototype of triple-antigen candidate against COVID-1
expresspharma
May 20, 2020
Reportedly, the vaccine prototype is among the first in the world for VLP of SARS CoV-2 virus.
-
US likely to get first access to Sanofi’s Covid-19 vaccine candidate
pharmaceutical-technology
May 15, 2020
French pharmaceutical giant Sanofi CEO Paul Hudson has said that the US will likely have first access to its Covid-19 vaccine if it succeeds.
-
Exyte and Univercells Technologies to deploy vaccine production plants
expresspharma
May 15, 2020
The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the COVID-19 pandemic.
-
Coronavirus vaccine possible in about a year, says EU agency
expresspharma
May 15, 2020
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so beginning of 2021," said Marco Cavaleri, head of vaccines, European Medicines Agency.
-
Sanofi says its COVID-19 vaccine will available in all countries
expresspharma
May 15, 2020
The statement comes after the French government took objection to Sanofi CEO’s comment that the US will get first access to the company’s vaccine.
-
Exyte and Univercells Join Forces
contractpharma
May 15, 2020
Partner for rapid deployment of vaccine production plants in the wake of the COVID-19 crisis.